CAS: 2313526-86-0
N-(2-(1H-1,2,4-Triazol-1-yl)-5-(trifluoromethoxy)phenyl)-4-(cyclopropylmethoxy)-3-methoxybenzamide
CAS:2313526-86-0
Fórmula:
C21H19F3N4O4
Pureza:
99.92%
Peso molecular:
448.3952
Ref: IN-DA01KL03
| 5mg | 552,00 € | ||
| 10mg | A consultar | ||
| 50mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 10 de Diciembre de 2024
N-(2-(1H-1,2,4-Triazol-1-yl)-5-(trifluoromethoxy)phenyl)-4-(cyclopropylmethoxy)-3-methoxybenzamide
CAS:2313526-86-0
N-(2-(1H-1,2,4-Triazol-1-yl)-5-(trifluoromethoxy)phenyl)-4-(cyclopropylmethoxy)-3-methoxybenzamide is a modulator of metabotropic glutamate receptors. It has been shown to be orally …
Fórmula:
C21H19F3N4O4
Pureza:
Min. 95%
Peso molecular:
448.4 g/mol
Ref: 3D-NSD52686
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 21 de Enero de 2025
VU6012962
CAS:2313526-86-0
VU6012962 is an orally bioavailable negative allosteric modulator of CNS-penetrant metabotropic glutamate receptor 7(mGlu7; IC50: …
Fórmula:
C21H19F3N4O4
Pureza:
97% - 98.31%
Forma y color:
Solid
Peso molecular:
448.4
Ref: TM-T13323
| 1mg | 36,00 € | ||
| 2mg | 52,00 € | ||
| 5mg | 78,00 € | ||
| 10mg | 124,00 € | ||
| 25mg | 233,00 € | ||
| 50mg | 418,00 € | ||
| 100mg | 611,00 € | ||
| 1mL*10mM (DMSO) | 87,00 € |
Entrega estimada en Estados Unidos, el Martes 11 de Febrero de 2025
